Patient stories are a powerful way to highlight ways that healthcare policies affect the everyday lives of people with rheumatic diseases.
How Rheumatologists Are Paid: Luke Barré, MD, Joins AMA Committee That Helps Shape Physician Fee Schedule
The American Medical Association’s Relative Value Update Committee advises the Centers for Medicare & Medicaid Services on appropriate reimbursement rates for specialty services. Luke Barré, MD, MPH, RhMSUS, is learning the ropes as the ACR’s newest representative.
How the U.S. Will Set Up New Medicare Drug Price Talks
WASHINGTON—The U.S. government will soon begin hiring experts and collecting the data needed to launch direct negotiations over prescription drug prices for older and disabled people, a top Biden administration official told Reuters. President Joe Biden last week signed into law the Inflation Reduction Act, introducing new policies to tackle climate change, taxes and the…
ACR President, Affiliate Society Council Hold First Town Hall
In late August, leaders of state and local rheumatology societies from across the nation connected with each other and with ACR president Ken Saag, MD, in a roundtable-style meeting. State and local rheumatology leaders shared local updates, successes and challenges and discussed ACR initiatives.
An Update from the RheumPAC Chair on the 117th Congress
RheumPAC has been working to ensure that individual legislators understand what rheumatology practices and patients face when it comes to delivering high quality care to those with rheumatic diseases and advocating for policies to support affordability of care, workforce expansion, prior authorization reform and fair reimbursement levels.
September Updates from the ACR Insurance Subcommittee
In recent months, the ISC has engaged with payers to reduce administrative burden on practices and continues to advocate to the CMS for the use of complex administration codes for biologics.
Florida Law Puts Drug Pricing by Pharmacy Benefit Managers Under a Microscope Once Again
As of July 1, a Florida bill increases oversight of pharmacy benefit managers and offers some protection for pharmacies. However, the legislation has limited effects on patients and providers, highlighting the need for additional reform.
Ongoing Advocacy Efforts Seek Use of Complex Administration Codes for Biologics
Ongoing ACR advocacy efforts are working to keep biologic drugs accessible to rheumatology patients, defending the ability of rheumatology practices to use the complex chemotherapy codes for administration of biologic therapies.
How to Connect with Your Members of Congress During the August Recess
Many members of Congress return to their home states and districts in August, making it a great time to engage them in local conversations about healthcare policies and how they affect rheumatology practices and patients.
The ACR Responds to Impact of the Dobbs v. Jackson Decision on Rheumatology Patients and Providers
The ACR and a new Access to Reproductive Health Care Task Force are working to ensure patients with rheumatic disease—particularly women—have access to the medications and treatments they need, including methotrexate, and that rheumatology providers are able to maintain trusting relationships with and advise their patients on all matters relevant to the management of their rheumatic diseases.
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 86
- Next Page »